Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a limited sampling strategy for the estimation of isoniazid exposure considering N-acetyltransferase 2 genotypes in Korean patients with tuberculosis. | Tuberculosis (Edinb) | 2021 | 33548864 | PubTator, text mining | PubMed |
| A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis. | Commun Biol | 2021 | 33536631 | PubTator, text mining | PubMed |
| Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature. | J Pers Med | 2021 | 33530463 | PubTator, text mining | PubMed |
| Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. | Pharmgenomics Pers Med | 2021 | 33519226 | PubTator, text mining | PubMed |
| Population pharmacokinetic model of isoniazid in patients with tuberculosis in Tunisia. | Int J Infect Dis | 2021 | 33476758 | PubTator, text mining | PubMed |
| Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy. | Pharmaceuticals (Basel) | 2021 | 33450833 | PubTator, text mining | PubMed |
| Generation of proliferating human adult hepatocytes using optimized 3D culture conditions. | Sci Rep | 2021 | 33436872 | PubTator, text mining | PubMed |
| Current insights into the genetics of food allergy. | J Allergy Clin Immunol | 2021 | 33436162 | PubTator, text mining | PubMed |
| ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation. | Cancers (Basel) | 2021 | 33429909 | PubTator, text mining | PubMed |
| Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics. | Genet Med | 2021 | 33420348 | PubTator, text mining | PubMed |
| Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia. | Pharmacogenomics | 2021 | 33399479 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. | Clin Pharmacol Ther | 2021 | 33336382 | PubTator, text mining | PubMed |
| PtmC Catalyzes the Final Step of Thioplatensimycin, Thioplatencin, and Thioplatensilin Biosynthesis and Expands the Scope of Arylamine N-Acetyltransferases. | ACS Chem Biol | 2021 | 33314918 | PubTator, text mining | PubMed |
| Collagen type XVIII alpha 1 chain (COL18A1) variants affect the risk of anti-tuberculosis drug-induced hepatotoxicity: A prospective study. | J Clin Lab Anal | 2021 | 33296124 | PubTator, text mining | PubMed |
| [Drug interactions in dermatological systemic treatment]. | Hautarzt | 2021 | 33242135 | PubTator, text mining | PubMed |
| Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection. | Clin Infect Dis | 2021 | 33215187 | PubTator, text mining | PubMed |
| The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. | Hum Genet | 2021 | 33180176 | PubTator, text mining | PubMed |
| A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators. | Pharmacogenet Genomics | 2021 | 33165168 | PubTator, text mining | PubMed |
| Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes. | Arch Toxicol | 2021 | 33136180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=37